The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lansoprazole Krka 30 mg Gastro-resistant Capsules, hard

30 milligram(s) Gastro-resistant capsule

Krka d.d., Novo mestoPA1347/062/002

Main Information

Trade NameLansoprazole Krka 30 mg Gastro-resistant Capsules, hard
Active SubstancesLansoprazole
Strength30 milligram(s)
Dosage FormGastro-resistant capsule
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/062/002

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC03 lansoprazole


Licence Issued23/09/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0008-033-033
Interchangeable List DocumentPDF of Interchangeable List
« Back